Skip to main content

Clustering #Countries on #Development Indicators Reveals Structure Relevant for #H5N1 #Mortality Analysis

 


Abstract

Infectious diseases are often observed to have different epidemiology in different countries, which arises due to various factors including those that are ecological, socioeconomic, and healthcare-related. Such variability can sometimes be best captured through looking at groups of countries that are similar within-group but variable between-group. In this study we use statistical learning methods to generate data-driven disease-centric groupings of countries rather than those developed for administrative or political reasons by e.g. the WHO, World Bank, and the United Nations. In particular, we apply hierarchical clustering to group countries based on shared disease-relevant characteristics for zoonotic H5N1 influenza. Using statistical methods such as classification and regression trees (CART)-based imputation and dynamic tree cutting, the analysis accounts for missing data and identifies epidemiologically (rather than politically or economically) meaningful clusters. Applying health metric relevant indicators, we cluster the countries of the world and using a Bayesian approach compute CFRs of zoonotic H5N1 influenza before comparing across clusters. We find that countries with stronger healthcare systems and lower poverty rates tend to have lower and more stable CFRs, whereas resource-limited settings face higher fatality risks.


Competing Interest Statement

The authors have declared no competing interest.


Funding Statement

MKA was supported by the Schlumberger Foundation Faculty for the Future. TH was supported by the Wellcome Trust (227438/Z/23/Z) and the Medical Research Council (UKRI483).

Source: MedRxIV, https://www.medrxiv.org/content/10.1101/2025.11.08.25339808v1

____

Comments

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...